The Radiation ProtEction for Dose RedUction in the Cardiac CathEter Lab Study: the REDUCE Trial

Launched by LIVERPOOL HEART AND CHEST HOSPITAL NHS FOUNDATION TRUST · Mar 12, 2025

Keywords

ClinConnect Summary

The REDUCE Trial is a study designed to test a new device called RAMPART, which aims to protect doctors and nurses from harmful radiation while they perform heart procedures. Medical professionals often use X-rays to guide these procedures, but the radiation can lead to serious health issues over time, such as cancer and eye problems. Currently, they wear heavy protective clothing to reduce exposure, which can be uncomfortable. The RAMPART device may help lower radiation levels without the need for heavy gear, making their work safer and more comfortable.

To be part of this study, participants should be adults over 18 years old who are scheduled for a heart procedure that uses X-ray guidance. However, this trial will not include individuals under 18, pregnant women, or those unable to give consent. Participants can expect to have their radiation exposure measured while using this new protection device compared to standard gear. The goal is to see if RAMPART can better safeguard healthcare workers in the cardiac catheter lab, ultimately improving their health and safety.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • All procedures involving adult patients (\>18 year of age)
• • Male or female patients
• • Planned to undergo either an elective or urgent coronary intervention procedure involving ionising radiation in the cardiac catheter lab, via the right and or left radial arteries.
• Exclusion Criteria:
• • Procedures involving patients less than 18 years of age
• • Patients unable to give valid consent
• • Pregnancy
• • Femoral approach procedure